ESGCT/BSGCT Annual Congress

195 days

8 hours

43 mins

Print Programme
Education Session
Tuesday 22 October 2019
Room 114-115
Organiser: Hildegard Büning, MHH
09:15-09:30 Educ 1: Opening words and Chair 
Hildegard Büning
Hannover Medical School
Introduction: Highlights in gene therapy in 2019
09:30-11:00 Educ 2: Of vectors and other modes of delivery

INV015: Els Verhoeyen, EVIR/CIRI/INSERM U1111, Lyon
& Axel Schambach, Hannover Medical School 
Comparing lentiviral vectors and alpha retroviral vectors:
Both powerful tools for gene therapy 
          
INV016: Karim Benihoud, CNRS UMR 8203, University of Paris Sud
& Hildegard Büning, Hannover Medical School
Adenovirus and AAV vectors – zooming in immunogenicity, vaccination and targeting

INV017: Matthew Porteus, Stanford University, CA
Delivery of genome editing reagents
 
11:00- 11:30 COFFEE BREAK
11:30-12:30 Educ 3: Engineering cells for therapy

INV018: Marc Güell, Pompeu Fabra University, Barcelona
Precise engineering of mammalian genomes

INV019: Mireya Plass, Centre for Genomic Regulation, Barcelona
Understanding cellular proliferation and differentiation using single-cell transcriptomics
 
12:30-13:00 Educ 4: News on cancer gene therapy strategies

INV020: Hinrich Abken, Universitätsklinikum Regensburg
CAR T cells, CAR NK, off-the-shelf CAR cells, CAR-Treg
 
13:00-14:00 LUNCH
14:00-16:30 Educ 5: News on gene/cell therapy I

INV021: Jose Carlos Segovia-Sanz, CIEMAT/CIBERER, Madrid
Lentiviral gene therapy and gene editing for the treatment of metabolic diseases

INV022: Daniel Grinberg, University of Barcelona
Neuronopathic lysosomal storage diseases: cellular and animal models to test therapeutic approaches

INV023: Juan Jose Toledo-Aral, Instituto de Biomedicina de Sevilla - IBiS
Cell therapy for Parkinson’s disease

INV024: Eduard Serra, IGTP, Barcelona
Reprogramming benign tumours of the peripheral nervous system
associated to Neurofibromatosis Type 1 as a model system

Discussion